Labman Automation Limited

In response to the growing need for sustainable practices in pharmaceutical manufacturing, our project aims to transform the industry by incorporating cutting-edge technology and data-driven approaches to create eco-friendly factories for the future. Our vision is to revolutionise pharmaceutical manufacturing by integrating robotics and automation, along ...

Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Besides established risk factors such as elevated blood pressure, blood glucose or lipid levels, circulating proteomic as well as genetic markers allow further stratification of patients. While some of these markers can be measured routinely in low-threshold healthcare institutions, ...

The RAP-IDD project (Rapid Development of Intracellular Drug Delivery Innovations), led by the UK SME Micropore Technologies (Micropore), supported by SME Labman Automation (Labman) and CPI, aims to develop and validate a new technology platform to encapsulate genomic material (RNA and DNA) in protective nanoparticles and integrate this with high-throughp...

To meet both the demands of a growing population and reduce the environmental impact of agriculture, there is an acute need to radically improve crop production systems globally. Vertical farming, where crops are produced in controlled environments with optimised growth mediums, water, air and nutrients, is a highly promising alternative to traditional ag...

A feasibility study undertaken by a UK engineering company who are looking to expand their business into the Chinese market. The study facilitates the gathering of the information required to adapt an existing product and bring two new products to market as well as form commercial partnershipes with two Chinese companies. The estimated impact of this stud...